[Individualized pharmaceutical consultations in the management of chemotherapy-induced XXXX ].

@entity1 @entity1209
In order to prevent and control the chemotherapy-induced @entity1209 (CINV), the military hospital Percy (Clamart, France) developed a systematic "CINV consultation". With 1.500 consultations conducted in 2013, the aim of this study was to confront professional practices and the @entity1 's point of view to assess the efficiency of this procedure and consider a restructuring to optimize it. A preliminary study was conducted: 30 medical records of @entity1 who had chemotherapy cure during 2013 have been analysed and 30 @entity1 have completed an evaluation questionnaire anonymously. @entity1 were very satisfied (63%) or satisfied (37%) of these consultations. Most of them (71%) said the consultations were useful before every cure, while 27% thought that the consultation at first cure or when the chemotherapy protocol changed was enough. CINV consultations were estimated as complementary of the medical consultation for 93% of the @entity1 . Most of the @entity1 (70%) never had CINV or just at the first cure. Furthermore, the anti-emetic treatment was adapted to the new chemotherapy emetic level in only 53% of protocol changes. @entity1 have expressed a real interest in these CINV consultations and the benefits they could get from them. Moreover, @entity1 ' side effects are stabilized faster thanks to those pharmaceutical interviews. In fact, it seems that these consultations are mostly needed for the first cure (until @entity1 stabilization) and when there is a chemotherapy protocol change.
